INOVIO AS
Similar Organizations
Love At First Swab
Love At First Swab is a biotechnology company.
More informations about "Inovio AS"
INOVIO Pharmaceuticals
INOVIO is a clinical-stage biotechnology company focused on developing DNA medicines to fight HPV-related diseases, cancer and infectious diseases.See details»
Leadership | INOVIO Pharmaceuticals
With a strong strategic vision and a focus on operational excellence and financial discipline, our dedicated team has extensive experience bringing products to market to benefit patients. Dr. …See details»
Corporate Presentation - s23.q4cdn.com
Nov 17, 2023 “INOVIO” and the INOVIO logo are trademarks and service marks of INOVIO. All other trademarks, service marks, trade names, ... • Prioritized pipeline and right-sized …See details»
Inovio COVID-19 vaccine - Wikipedia
In February 2020 after receiving details of the genetic sequence of the coronavirus, Inovio announced that it had produced a preclinical DNA-based vaccine as a potential therapy for COVID-19. Inovio is in competition to develop a coronavirus vaccine with numerous other companies, which were conducting preclinical or early-stage human research on more than 170 vaccine candidates, as of late June. In April 2020, Inovio began a Phase I trial of the COVID-19 vaccine …See details»
Inovio Pharmaceuticals, Inc. - INVESTORS & MEDIA
Nov 14, 2024 INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, …See details»
Inovio AS - Crunchbase Company Profile & Funding
Inovio AS is an Oslo, Norway-based gene delivery technology company. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log …See details»
Purpose, Mission and Values | INOVIO Pharmaceuticals
INOVIO is a clinical-stage biotechnology company committed to advancing DNA medicines to help save and protect lives worldwide. We are trailblazers in the DNA medicine field, working …See details»
Inovio Pharmaceuticals - Devex
Inovio's immunotherapies function exclusively in vivo, generating an antigen-specific immune response against targeted diseases in clinical trials to date. The science is at once, …See details»
Inovio Pharmaceuticals - Funding, Financials, Valuation & Investors
Inovio Pharmaceuticals has acquired 2 organizations. Their most recent acquisition was Bioject Medical Technologies on May 2, 2016 . They acquired Bioject Medical Technologies for $4.3M .See details»
Inovio Pharmaceuticals, Inc. - INOVIO Announces Corporate ...
Jul 19, 2022 INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to potentially treat and protect people from infectious diseases, cancer, and …See details»
Because The World Can't Wait - Reddit
Inovio Pharmaceuticals is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and …See details»
Home | INOVIO Pharmaceuticals
SUBSCRIBE FOR UPDATES FROM INOVIO Register to receive email alerts for INOVIO press releasesSee details»
Inovio Pharmaceuticals, Inc. - INOVIO Reports Third Quarter 2024 ...
Nov 14, 2024 INOVIO continued to advance its plans for a Phase 2 trial of INO-4201 as a heterologous boost to the FDA licensed Ebola vaccine, Ervebo®. A meeting is scheduled with …See details»
Inovio Pharmaceuticals, Inc. - INOVIO Expands Executive …
Nov 5, 2021 INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and …See details»
Inovio COVID-19 vaccine candidate to undergo WHO-sponsored …
Oct 28, 2021 Inovio Pharmaceuticals (NASDAQ:INO) says that its experimental COVID-19 vaccine INO-4800 will be one of the two vaccines being investigated in a large global Phase 3 …See details»
Inovio Pharmaceuticals, Inc. - INOVIO Announces Strategic ...
Jan 31, 2023 Data readouts for INOVIO's Phase 3 REVEAL2 trial for VGX-3100 and the second cohort from the Phase 1/2 trial for INO-3107 are expected to be announced in the first quarter …See details»
About Inovio | INOVIO Pharmaceuticals
SUBSCRIBE FOR UPDATES FROM INOVIO Register to receive email alerts for INOVIO press releasesSee details»
INOVIO Adds Thermo Fisher Scientific To Global Manufacturing …
Sep 8, 2020 Thermo Fisher joins other contract development and manufacturing organizations in INOVIO's global manufacturing consortium, enabling INOVIO to potentially scale commercial …See details»
INOVIO Reports Fourth Quarter 2021 and Year-End Financial Results
Mar 1, 2022 INOVIO's partner Advaccine completed enrollment of its 200-participant homologous and 267-participant heterologous boost trial with INO-4800 in China. INO-4800 …See details»